<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Smith PR</submitter><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Neurological Disorders and Stroke</funding><funding>NINDS NIH HHS</funding><pagination>6789</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8611098</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(1)</volume><pubmed_abstract>Processing bodies (p-bodies) are a prototypical phase-separated RNA-containing granule. Their abundance is highly dynamic and has been linked to translation. Yet, the molecular mechanisms responsible for coordinate control of the two processes are unclear. Here, we uncover key roles for eEF2 kinase (eEF2K) in the control of ribosome availability and p-body abundance. eEF2K acts on a sole known substrate, eEF2, to inhibit translation. We find that the eEF2K agonist nelfinavir abolishes p-bodies in sensory neurons and impairs translation. To probe the latter, we used cryo-electron microscopy. Nelfinavir stabilizes vacant 80S ribosomes. They contain SERBP1 in place of mRNA and eEF2 in the acceptor site. Phosphorylated eEF2 associates with inactive ribosomes that resist splitting in vitro. Col</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Functionally distinct roles for eEF2K in the control of ribosome availability and p-body abundance.</pubmed_title><pmcid>PMC8611098</pmcid><funding_grant_id>R01NS114018</funding_grant_id><funding_grant_id>R01 NS100788</funding_grant_id><funding_grant_id>R01NS100788</funding_grant_id><funding_grant_id>R01 NS114018</funding_grant_id><pubmed_authors>Lou TF</pubmed_authors><pubmed_authors>Loerch S</pubmed_authors><pubmed_authors>Campbell ZT</pubmed_authors><pubmed_authors>Stanowick AD</pubmed_authors><pubmed_authors>Smith PR</pubmed_authors><pubmed_authors>Kunder N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Functionally distinct roles for eEF2K in the control of ribosome availability and p-body abundance.</name><description>Processing bodies (p-bodies) are a prototypical phase-separated RNA-containing granule. Their abundance is highly dynamic and has been linked to translation. Yet, the molecular mechanisms responsible for coordinate control of the two processes are unclear. Here, we uncover key roles for eEF2 kinase (eEF2K) in the control of ribosome availability and p-body abundance. eEF2K acts on a sole known substrate, eEF2, to inhibit translation. We find that the eEF2K agonist nelfinavir abolishes p-bodies in sensory neurons and impairs translation. To probe the latter, we used cryo-electron microscopy. Nelfinavir stabilizes vacant 80S ribosomes. They contain SERBP1 in place of mRNA and eEF2 in the acceptor site. Phosphorylated eEF2 associates with inactive ribosomes that resist splitting in vitro. Col</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2026-05-09T17:19:58.89Z</modification><creation>2022-02-11T13:29:51.801Z</creation></dates><accession>S-EPMC8611098</accession><cross_references><pubmed>34815424</pubmed><doi>10.1038/s41467-021-27160-4</doi></cross_references></HashMap>